Video yükleniyor...

Video Yüklenemedi

Ana Sayfaya Dön

42,057 görüntüleme • 1 ay önce •via X (Twitter)

0 Yorum

Yorum bulunmuyor

Orijinal gönderinin yorumları burada görünecek

Benzer Videolar

Missed the Apex AI livestream on @pumpdotfun? Here's a quick recap and the full recording: Key Highlights: •⁠ ⁠Apex AI achieves 95%+ accuracy in early GI cancer detection, trained on over 1 million GI images. •⁠ ⁠Founder Sung Kim, former supercomputer architect (installed Korea’s largest supercomputer), developed Apex AI after his GI specialist cousin missed early-stage cancer signs in one of his patients. Product demo: •⁠ ⁠Tracks patient scans over time, clearly identifying and highlighting potential concerns. •⁠ ⁠Provides detailed visual indicators on images, simplifying and enhancing diagnostic accuracy. •⁠ ⁠Significantly outperforms traditional specialist diagnoses, dramatically improving early detection. Clinical Performance (GI Cancer Detection): •⁠ ⁠Human specialists (doctors): 67% accuracy, 69% sensitivity. •⁠ ⁠APEX AI: 95% accuracy (stomach), 99% (colon); high sensitivity and specificity. Market Opportunity: •⁠ ⁠GI healthcare market: $240 billion globally; Apex targets $240 million market share by 2028. •⁠ ⁠Partnerships include Seoul National University Hospital and Catholic University Hospital; Oracle collaboration for global cloud deployment in progress. Upcoming Goals: •⁠ ⁠KFDA approval anticipated by end of year. •⁠ ⁠FDA submission scheduled for 2026. •⁠ ⁠Expansion to U.S. and global markets. Apex AI is transforming GI cancer detection, making early diagnosis easy, reliable, and life-changing.

Apex AI

93,422 görüntüleme • 1 yıl önce